Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.31 EUR | 0.00% | 0.00% | -2.96% |
Valuation
Fiscal Period: December | 2023 |
---|---|
Capitalization 1 | 235.2 |
Enterprise Value (EV) 1 | 612.4 |
P/E ratio | 19.3 x |
Yield | - |
Capitalization / Revenue | 6.83 x |
EV / Revenue | 17.8 x |
EV / EBITDA | - |
EV / FCF | -89,13,024 x |
FCF Yield | -0% |
Price to Book | 0.53 x |
Nbr of stocks (in thousands) | 1,74,194 |
Reference price 2 | 1.350 |
Announcement Date | 15/03/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net sales 1 | 6.048 | 15.94 | 19.67 | 21.93 | 34.45 |
EBITDA 1 | 2.248 | 9.617 | 13.11 | 16.81 | - |
EBIT 1 | 0.1318 | 6.609 | 9.429 | 16.81 | 26 |
Operating Margin | 2.18% | 41.45% | 47.94% | 76.63% | 75.49% |
Earnings before Tax (EBT) 1 | -1.278 | 3.193 | 5.29 | 23.72 | 12.84 |
Net income 1 | -1.263 | 3.157 | 5.322 | 22.52 | 12.84 |
Net margin | -20.88% | 19.8% | 27.06% | 102.66% | 37.27% |
EPS | - | 0.0266 | 0.0448 | 0.1556 | 0.0700 |
Free Cash Flow | - | 6.114 | 7.669 | 49.31 | -68.71 |
FCF margin | - | 38.35% | 38.99% | 224.85% | -199.44% |
FCF Conversion (EBITDA) | - | 63.58% | 58.51% | 293.36% | - |
FCF Conversion (Net income) | - | 193.66% | 144.1% | 219.01% | - |
Dividend per Share | - | - | - | - | - |
Announcement Date | 17/04/20 | 06/03/21 | 25/02/22 | 31/03/23 | 15/03/24 |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net Debt 1 | 139 | 168 | 178 | 266 | 377 |
Net Cash position 1 | - | - | - | - | - |
Leverage (Debt/EBITDA) | 61.68 x | 17.46 x | 13.55 x | 15.85 x | - |
Free Cash Flow | - | 6.11 | 7.67 | 49.3 | -68.7 |
ROE (net income / shareholders' equity) | - | 1.86% | 2.82% | 6.66% | 2.85% |
ROA (Net income/ Total Assets) | - | 1.21% | 1.56% | 1.71% | 1.97% |
Assets 1 | - | 260 | 340.9 | 1,317 | 652.6 |
Book Value Per Share 2 | 1.330 | 1.590 | 1.590 | 2.510 | 2.530 |
Cash Flow per Share 2 | 0.0800 | 0.1000 | 0.0400 | 0.0600 | 0.0200 |
Capex | - | - | - | - | - |
Capex / Sales | - | - | - | - | - |
Announcement Date | 17/04/20 | 06/03/21 | 25/02/22 | 31/03/23 | 15/03/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- MLHAY Stock
- Financials Healthcare Activos Yield SOCIMI, S.A.